# Pennsylvania Healthcare Marketing Compliance Rules - State Board of Medicine and AG

Pennsylvania State Board of Medicine advertising rules and UTPCPL enforcement against healthcare marketing deception - with focus areas specific to PA's aesthetic, weight loss, and telehealth sectors.

Canonical page: https://regencompliance.ai/state/pennsylvania


## Overview

Pennsylvania healthcare marketing compliance operates under the Pennsylvania State Board of Medicine rules (49 Pa. Code Ch. 16), the Unfair Trade Practices and Consumer Protection Law (UTPCPL), and state-specific telehealth and supervision rules. The AG office has been active on compounded medication marketing and telehealth prescribing advertising.


## Pennsylvania State Board of Medicine

49 Pa. Code Ch. 16 covers physician advertising rules including specialty claim requirements, testimonial handling, guarantee restrictions, and supervision representations. The Board enforces against both individual physicians and practice entities and has been particularly active on aesthetic-practice marketing.


## State attorney general focus

UTPCPL provides AG consumer-protection authority. The PA AG has been active on compounded medication marketing and telehealth prescribing practices. UTPCPL also permits private action with treble-damages potential.


## Focus areas

- **Aesthetic practice supervision**: Pennsylvania enforces supervision requirements for non-physician injectors and aesthetic service providers. Marketing that implies independent practice has been a disciplinary focus.
- **Compounded medication marketing**: PA has been active on compounded GLP-1 and related medication marketing, particularly around brand-equivalence language and prescribing representations.
- **Telehealth prescribing advertising**: PA telehealth rules require specific standards that apply to providers marketing to PA residents. Marketing that minimizes clinical evaluation steps has drawn scrutiny.
- **UTPCPL private enforcement**: UTPCPL permits private action with treble damages - creating exposure to class-action litigation beyond AG enforcement.


## Patterns that draw enforcement attention

- **Non-physician injector independence language**: Board of Medicine supervision enforcement is active on this pattern.
- **Brand-equivalence claims for compounded medications**: PA AG has initiated enforcement under UTPCPL.
- **Telehealth marketing to PA residents without compliance framing**: PA telehealth rules apply regardless of provider location.
- **Guarantee language on medical outcomes**: 49 Pa. Code restricts; UTPCPL private-action exposure parallel.
- **Specialty misrepresentation**: Board of Medicine specialty-claim enforcement.


## Specialty notes

- Med spas - supervision enforcement is primary focus.
- Weight loss / telehealth - PA AG activity under UTPCPL.
- Aesthetic surgery - guarantee and specialty rules apply.
- Dental - PA State Board of Dentistry rules separate.
- Compounding-pharmacy-affiliated clinics - growing enforcement area.


## Disclaimer

This summary reflects general patterns in Pennsylvania healthcare marketing enforcement; it is not legal advice. For state-specific guidance on your practice, consult a Pennsylvania-licensed healthcare marketing attorney.

---

RegenCompliance is FDA/FTC compliance scanning software for healthcare marketing, operated by Regen Portal LLC. Educational compliance tool, not legal advice. Not affiliated with the FDA or FTC. Contact: support@regencompliance.ai. Full site index for AI agents: https://regencompliance.ai/llms.txt